International Journal of Medical and Pharmaceutical Research
2026, Volume-7, Issue 3 : 718-722
Research Article
Prevalence of Sleep Disorders in Children and Adolescents with Cerebral Palsy
 ,
 ,
 ,
 ,
Received
April 1, 2026
Accepted
May 5, 2026
Published
May 18, 2026
Abstract

Introduction: Sleep plays vital role in physical, emotional and cognitive development of children. Children with cerebral palsy (CP), sleep disturbances are frequent but often unrecognized and may exacerbate existing functional limitations.

Objective: To evaluate prevalence and pattern of sleep-related disturbances in children with CP and to analyse their association with CP type and clinical severity based on Gross Motor Function Classification System (GMFCS)level.

Materials and Methods: A cross sectional study conducted in paediatric department of tertiary care hospital. A total of 43 children aged 6 years to 15 years with established diagnosis of CP were included. Clinical and demographic details, including GMFCS level and CP subtype, were recorded. Sleep disturbances were assessed using the Sleep Disturbance Scale for Children (SDSC), a validated parent-reported questionnaire that evaluates six domains of sleep disturbances. Statistical analysis performed using the Kruskal–Wallis H-test and chi-square tests, with p < 0.05 considered statistically significant.

Results: Initiating and maintaining sleep was most affected domain (prevalence30.2%), followed by wake transition disorders (27.9%) and excessive day time somnolence (27.9%). Significant associations were found between sleep disturbance scores and CP subtype as well as GMFCS level. Children with spastic quadriplegia, extrapyramidal CP, and GMFCS Grade 5 had highest sleep disturbance scores (p< 0.05). Arousal disorders showed no significant association.

Conclusion: Sleep disturbances are common in children with CP and correlate significantly with clinical severity. Routine sleep screening and tailored interventions should be integral to CP management.

Keywords
INTRODUCTION

Sleep is an essential biological function that plays a crucial role in the physical growth, neurocognitive development and emotional regulation of children and adolescents [1]. Sleep disturbances during this critical period can have wide-ranging consequences on health, behaviour and academic performance [2]. These challenges are particularly concerning in children with neurodevelopmental disorders such as cerebral palsy (CP), where sleep problems may further exacerbate functional impairments [3].Cerebral palsy is a group of permanent disorders affecting movement and posture, caused by non-progressive disturbances in the developing fetal or infant brain [4]. It is the most common physical disability in childhood, with a global prevalence of approximately 2 per 1,000 live births [5]. Its prevalence ranges from 1.3 to 4.4 per 1,000 live births. CP often arises in association with preterm birth, perinatal hypoxia or brain injury, with periventricular leukomalacia being a common cause in preterm infants [5-7].Although CP is not progressive, its clinical manifestations evolve with age. It is classified based on motor type (e.g., spastic hemiplegia, diplegia, quadriplegia) and severity, commonly graded using the Gross Motor Function Classification System (GMFCS) [8]. In addition to motor dysfunction, children with CP frequently experience comorbidities such as seizures, feeding difficulties, and notably, sleep disturbances [8].Studies suggest that 23% to 46% of children with CP suffer from sleep problems, including difficulty initiating and maintaining sleep, sleep-disordered breathing and daytime somnolence [8]. These may result from spasticity, pain, immobility, or associated conditions like epilepsy and gastroesophageal reflux. Higher GMFCS levels and severe CP subtypes are often linked to greater sleep disruption [9].

 

Despite their prevalence, sleep disturbances in CP often remain underrecognized and undertreated. Therefore, this study aims to evaluate the prevalence and patterns of sleep disturbances in children and adolescents with cerebral palsy and to analyse their correlation with clinical severity based on CP subtype and GMFCS level, to do early interventions and improve quality of life.

 

MATERIALS AND METHODS

Study Design and Setting

This cross-sectional observational study was conducted in the outpatient department (OPD) of a tertiary care hospital. The primary objective was to assess the prevalence and pattern of sleep disturbances in children and adolescents diagnosed with cerebral palsy (CP) and to evaluate their association with clinical severity indicators such as CP subtype and Gross Motor Function Classification System (GMFCS) level.

 

Study Population

The study included a total of 43 children aged between 6 and 15 years who had a establised diagnosis of cerebral palsy. Participants were selected through consecutive sampling during their routine follow-up visits to the paediatric OPD. Written informed consent was obtained from the parents or legal guardians prior to enrolment in the study.

 

Inclusion and Exclusion Criteria

Children aged 6 to 15 years with a clinical diagnosis of cerebral palsy were included in the study. Children were excluded if they were currently on medications known to affect sleep, had acute illnesses at the time of evaluation, or if their parents or caregivers declined to provide consent.

 

Data Collection

Detailed demographic and clinical data were recorded using a structured proforma. This included age, sex, address, socioeconomic status (as per the modified Kuppuswamy scale), weight, height, body mass index (BMI) and head circumference. Clinical variables such as type and aetiology of CP, GMFCS level, daytime and night-time sleep duration, comorbidities, bed-sharing practices, and history of medications affecting sleep were also documented.

 

Sleep Assessment Tool

Sleep disturbances were assessed using the Sleep Disturbance Scale for Children (SDSC), a validated parent-reported questionnaire consisting of 26 items rated on a five-point Likert scale (1 = never to 5 = always). The SDSC evaluates six major domains of sleep disturbances: disorders of initiating and maintaining sleep (items 1, 2, 3, 4, 5, 10, 11), sleep breathing disorders (items 13, 14, 15), disorders of arousal (items 17, 20, 21), sleep-wake transition disorders (items 6, 7, 8, 12, 18, 19), disorders of excessive somnolence (items 22, 23, 24, 25, 26), and sleep hyperhidrosis (items 9, 16). Domain-specific scores were calculated by summing the scores of the corresponding items. Higher scores indicated greater severity of disturbance in that domain.

 

Statistical Analysis

All collected data were entered in Microsoft Excel and analysed using IBM SPSS version 25.0. Descriptive statistics such as mean and standard deviation were used for continuous variables, while categorical variables were expressed as frequencies and percentages. The Kruskal–Wallis H-test was applied to compare sleep domain scores across different CP types and GMFCS levels. Chi-square tests were used to evaluate associations between categorical and ordinal variables where appropriate. A p-value of less than 0.05 was considered statistically significant.

 

RESULTS:

The study included 43 children with cerebral palsy aged between 6 and 15 years. The age group distribution showed that the majority of participants were in the 6–11 years range, with 32.6% in the 9–11 years group and 30.2% in the 6–8 years group (Table 1). The study had a male predominance (62.8%) (Table 1). Socioeconomic status evaluation revealed that the largest group belonged to Class 4 (55.8%) (Table 1).With respect to the type of cerebral palsy, spastic hemiplegia was most commonly observed (44.2%), followed by spastic quadriplegia and diplegia (23.3% each), and extra pyramidal type (9.3%) (Table 1). The distribution of GMFCS levels showed that 41.9% of the participants were classified as Grade 5, indicating the most severe motor impairment, followed by Grade 1 (27.9%), Grade 2 (18.6%), and Grade 3 (11.6%) (Table 1). Among clinical factors, 32.6% of children had a history of seizures. Bed-sharing was reported in 60.5% of cases. Analysis of sleep disturbance domains based on SDSC scores showed that the highest mean scores and prevalence were noted in initiating and maintaining sleep (16.88 ± 5.84, 30.2%), followed by excessive somnolence (8.23 ± 3.24, 27.9%) and wake transition disorders (8.09 ± 3.40, 27.9%). The lowest average scores were found in arousal disorders (3.09 ± 0.43, 4.7% and 16.3 %) (Table 2 and 3).When analysed by type of CP, statistically significant differences were observed across groups in several sleep domains. Spastic quadriplegic and extra pyramidal CP types showed the highest mean scores for initiating and maintaining sleep, wake transition disorders, excessive somnolence, and sleep hyperhidrosis. The result confirmed that these differences were significant (p < 0.05) in all domains except arousal disorders (p = 0.5019), indicating that the type of CP has a strong influence on the severity and pattern of sleep disturbances (Table 4).In a similar analysis by GMFCS level, children classified as Grade 5 exhibited the most pronounced sleep problems across all domains except for arousal disorders and sleep hyperhidrosis. The difference in domain scores was statistically significant for initiating and maintaining sleep (p = 0.0002), wake transition disorders (p < 0.0001), and excessive somnolence (p = 0.0003). Sleep hyperhidrosis showed a borderline association (p = 0.0536), while arousal disorders were not significantly different across grades (p = 0.7988) (Table 5).Overall, the findings demonstrate a strong association between clinical severity—both in terms of CP type and GMFCS level—and the presence of sleep disturbances. Children with more severe motor involvement (spastic quadriplegia, extra pyramidal types, and GMFCS Grade 5) experienced significantly greater difficulties with sleep initiation, maintenance, and daytime sleepiness. These results underscore the importance of routine sleep assessment in children with CP, particularly those with greater motor impairment.

 

Table 1: Demographic Distribution

Parameter

Subcategory

Number (n)

Percentage (%)

Age Group (years)

6–8

13

30.2%

 

9–11

14

32.6%

 

12–14

11

25.6%

 

15–16

5

11.6%

Sex

Male

27

62.8%

 

Female

16

37.2%

Socioeconomic Status (SES)

Class 2

5

11.6%

 

Class 3

14

32.6%

 

Class 4

24

55.8%

GMFCS Level

Grade 1

12

27.9%

 

Grade 2

8

18.6%

 

Grade 3

5

11.6%

 

Grade 5

18

41.9%

Type of Cerebral Palsy

Spastic Hemiplegic

19

44.2%

 

Spastic Quadriplegic

10

23.3%

 

Spastic Diplegic

10

23.3%

 

Extra Pyramidal

4

9.3%

 

Mixed

0

-

 

Table 2: Prevalence of Sleep-Related Problems in Children with Cerebral Palsy

Sleep Problem Domain

Number Affected

Percentage (%)

Initiating & Maintaining Sleep

13

30.2%

Breathing Disorders

7

16.3%

Arousal Disorders

2

4.7%

Wake Transition Disorders

12

27.9%

Excessive Somnolence

12

27.9%

 

Table 3: Type of CP-wise Analysis Association of Sleep Disturbance Scores

Sleep Domain

Spastic Hemiplegic (Mean ± SD)

Spastic Diplegic (Mean ± SD)

Spastic Quadriplegic (Mean ± SD)

Extra Pyramidal (Mean ± SD)

Test Statistic (H)

P-value

Initiating & Maintaining Sleep

13.63 ± 2.75

13.50 ± 2.55

23.90 ± 4.89

23.25 ± 4.19

24.89

<0.0001

Breathing Disorders

3.37 ± 0.50

3.60 ± 0.97

5.10 ± 0.99

3.00 ± 0.00

20.38

0.0001

Arousal Disorders

3.00 ± 0.00

3.20 ± 0.63

3.20 ± 0.63

3.00 ± 0.00

2.36

0.5019

Wake Transition Disorders

5.84 ± 1.86

8.50 ± 3.78

10.30 ± 2.58

12.25 ± 2.50

21.38

0.0001

Excessive Somnolence

6.74 ± 1.73

7.00 ± 2.83

11.50 ± 3.75

10.25 ± 1.50

17.03

0.0007

Sleep Hyperhidrosis

2.68 ± 0.89

2.90 ± 1.29

4.20 ± 1.48

4.00 ± 0.00

10.73

0.0132

 

Table 4: GMFCS Level-wise Association of Sleep Disturbance Scores

Sleep Domain

Grade 1 (Mean ± SD)

Grade 2 (Mean ± SD)

Grade 3 (Mean ± SD)

Grade 5 (Mean ± SD)

Test Statistic (H)

P-value

Initiating & Maintaining Sleep

12.58 ± 1.31

13.88 ± 2.30

14.00 ± 2.35

21.89 ± 5.78

19.25

0.0002

Breathing Disorders

3.50 ± 0.52

3.25 ± 0.46

3.20 ± 0.45

4.39 ± 1.29

8.52

0.0364

Arousal Disorders

3.17 ± 0.58

3.00 ± 0.00

3.00 ± 0.00

3.11 ± 0.47

1.01

0.7988

Wake Transition Disorders

6.17 ± 2.33

5.38 ± 0.00

6.20 ± 0.00

11.11 ± 2.78

27.02

<0.0001

Excessive Somnolence

5.83 ± 0.94

6.75 ± 0.74

7.60 ± 1.10

10.67 ± 3.45

19.16

0.0003

Sleep Hyperhidrosis

3.00 ± 0.95

2.12 ± 0.35

3.20 ± 1.30

3.83 ± 1.38

7.66

0.0536

 

DISCUSSION

Our study demonstrated a significant association between GMFCS level and sleep disturbance domains such as initiating and maintaining sleep (p = 0.0002), wake transition disorders (p < 0.0001), and excessive somnolence (p = 0.0003). This suggests that more severely affected children experience greater sleep disruption. In contrast, Dhivya et al. and Adiga et al. [13] did not find a statistically significant association between GMFCS level and sleep disturbance (p = 0.448 in Dhivya et al.) [10]. However, Domenico Romeo et al. did report a significant correlation between GMFCS level 5 and poor sleep quality, aligning more closely with our findings [15].In the current study, spastic hemiplegia was the most common subtype (44.2%), followed by spastic quadriplegia and diplegia (23.3% each), and extrapyramidal type (9.3%). However, when analysing sleep disturbance severity, children with spastic quadriplegia and extra pyramidal CP had the highest mean scores in most domains. This association was statistically significant in domains such as initiating and maintaining sleep, wake transition disorders, excessive somnolence  and sleep hyperhidrosis (p < 0.05). Dhivya et al. [10] also found spastic quadriplegia to be significantly associated with higher total pathological SDSC scores (42.85%, p = 0.02), echoing our results. These findings suggest that children with widespread motor involvement are more susceptible to poor sleep due to increased dependency, immobility, contractures, bed sores, pathological fractures and associated comorbidities. In our study, 32.6% of children had a history of seizures. In contrast, Dhivya et al. [10] reported a much higher seizure prevalence at 74.28%. However, both studies agree that epilepsy is an important comorbidity in children with CP, which can significantly impair sleep. While our study did not analyse seizure presence with SDSC scores, Dhivya et al. found a significant association between seizure history and total sleep disturbance (p = 0.0315) [10]. Bed sharing was reported in 60.5% of our participants, closely resembling Dhivya et al.'s [10] report of 74.29%. Although not directly assessed for correlation in our study, bed sharing may be influenced by functional dependency or seizure monitoring.Our study revealed that the most common sleep disturbance domain was initiating and maintaining sleep (30.2%), followed by wake transition disorders (27.9%) and excessive somnolence (27.9%). These findings are similar to Dhivya et al., where Disorders of Initiating and Maintaining Sleep (DIMS) were present in 31.43%, followed by sleep breathing disorders (21.43%), excessive sleepiness (14.29%), and sleep hyperhidrosis (11.43%). In comparison, Adiga et al. [13] reported DIMS in 50% of their study and a total pathological score in 36%, which was higher than our total prevalence (24.28%). Newmanet al. [11] observed DIMS in 24.3% of children, which is lower than our study but still identifies this domain as a common issue in CP children. Our results reinforce the fact that sleep initiation and maintenance are disproportionately affected in this population, potentially due to discomfort, spasticity, positioning issues, and caregiver-dependent sleep environments. Although our study did not assess caregiver sleep patterns, Dhivya et al. reported that 32.86% of caregivers had poor sleep quality (PSQI >5), which was significantly associated with child sleep disturbance scores in multiple domains including DIMS, SWTD, and SHY. This highlights the bidirectional impact of sleep health in children and caregivers, emphasizing the need for family-cantered sleep assessments in future studies.

 

CONCLUSION

This study highlights a high prevalence of sleep disturbances in children with cerebral palsy, particularly in domains of initiating and maintaining sleep (30.2%), wake transition disorders (27.9%), and excessive somnolence (27.9%). Spastic hemiplegia was the most common CP type (44.2%), with Grade 5 being the most frequent GMFCS level (41.9%). Significant associations were found between sleep disturbances and both CP type and GMFCS level, especially among children with spastic quadriplegia, extrapyramidal CP and those in GMFCS Grade 5. Arousal disorders showed no significant variation. These findings underscore the importance of incorporating routine sleep assessments and targeted management strategies into CP care.

 

Limitations

The study’s small sample size and cross-sectional design limit the generalizability and causal inference of findings. Sleep disturbances were assessed through caregiver-reported questionnaires without objective sleep measures like polysomnography. The absence of a control group and unmeasured factors such as pain, environmental influences, sensory impairment, cognitive impairment, and detailed seizure characteristics may have affected the accuracy of sleep disturbance assessment.

 

REFERENCES:

  1. Panteliadis C, Panteliadis P, Vassilyadi F. Hallmarks in the history of cerebral palsy: from antiquity to mid-20th century. Brain Dev. 2013;35(4):285–92.
  2. Odding E, Roebroeck ME, Stam HJ. The epidemiology of cerebral palsy: incidence, impairments and risk factors. DisabilRehabil. 2006;28(4):183–91.
  3. Hirtz D, Thurman DJ, Gwinn-Hardy K, Mohamed M, Chaudhuri AR, Zalutsky R. How common are the "common" neurologic disorders? Neurology. 2007;68(5):326–37.
  4. Oskoui M, Coutinho F, Dykeman J, Jetté N, Pringsheim T. An update on the prevalence of cerebral palsy: a systematic review and meta-analysis. Dev Med Child Neurol. 2013;55(6):509–19.
  5. Liu JM, Li S, Lin Q, Li Z. Prevalence of cerebral palsy in China. Int J Epidemiol. 1999;28(5):949–54.
  6. Serdaroğlu A, Cansu A, Ozkan S, Tezcan S. Prevalence of cerebral palsy in Turkish children between the ages of 2 and 16 years. Dev Med Child Neurol. 2006;48(6):413–6.
  7. Banerjee TK, Hazra A, Biswas A, Ray J, Roy T, Raut DK, et al. Neurological disorders in children and adolescents. Indian J Pediatr. 2009;76(2):139–46.
  8. Dutt R, Roduta-Roberts M, Brown CA. Sleep and Children with Cerebral Palsy: A Review of Current Evidence and Environmental Non-Pharmacological Interventions. Children (Basel). 2015 Feb 27;2(1):78-88.
  9. Jan M.M. Cerebral palsy: Comprehensive review and update. Ann. Saudi Med. 2006;26:123–132.
  10. Dhivya J, Rebois AM. Sleep-related problems in children with cerebral palsy and its correlation with sleep disturbance in primary caregivers. Int J Acad Med Pharm. 2023;5(4):716–21.
  11. Newman CJ, O'Regan M, Hensey O. Sleep disorders in children with cerebral palsy. Dev Med Child Neurol2006;48:564–8
  12. Kulkarni S, Jadhav TS. Prevalence of Sleep Disorders in Children with Cerebral Palsy; A Questionnaire-based Observational Study. J PediatrNeurosci. 2021 Oct-Dec;16(4):269-272. doi: 10.4103/jpn.JPN_205_20. Epub 2021 Jul 12. PMID: 36531766; PMCID: PMC9757523.
  13. Adiga D, Gupta A, Khanna M, Taly AB, Thennarasu K. Sleep disorders in children with cerebral palsy and its correlation with sleep disturbance in primary caregivers and other associated factors. Ann Indian AcadNeurol2014;17:473–6.
  14. Löwing K, Gyllensvärd M, Tedroff K. Exploring sleep problems in young children with cerebral palsy - A population-based study. European Journal of Paediatric Neurology. 2020 Sep;28:186–92.
  15. Romeo DM, Brogna C, Quintiliani M, Baranello G, Pagliano E, Casalino T, et al. Sleep disorders in children with cerebral palsy: neurodevelopmental and behavioral correlates. Sleep Med 2014;15:213–8.
Recommended Articles
Research Article Open Access
CEREBO: A Portable Device for Non-invasive Detection of Intracranial Hematomas in Real Time
2025, Volume-6, Issue 6 : 2313-2319
Research Article Open Access
Clinico-radiological Profile and Surgical Outcomes in Patients with Spinal Tuberculosis: A Prospective Observational Study
2025, Volume-6, Issue 6 : 2320-2324
Research Article Open Access
Evaluation of Dose-Dependent Anticonvulsant Effects of Nifedipine in Pilocarpine-Treated Zebrafish
2026, Volume-7, Issue 3 : 900-905
Research Article Open Access
Evaluating The Add-on Effect of Ardraka Arka with Standard Care in Managing Tamaka Shwasa (Bronchial Asthma) in Children
2026, Volume-7, Issue 3 : 736-746
International Journal of Medical and Pharmaceutical Research journal thumbnail
Volume-7, Issue 3
Citations
19 Views
22 Downloads
Share this article
License
Copyright (c) International Journal of Medical and Pharmaceutical Research
Creative Commons Attribution License Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
IJMPR open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.
Logo
International Journal of Medical and Pharmaceutical Research
About Us
The International Journal of Medical and Pharmaceutical Research (IJMPR) is an EMBASE (Elsevier)–indexed, open-access journal for high-quality medical, pharmaceutical, and clinical research.
Follow Us
facebook twitter linkedin mendeley research-gate
© Copyright | International Journal of Medical and Pharmaceutical Research | All Rights Reserved